Psychiatry and Neurology, Neurology · Durham, NC
NPI
1013088350
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
6114 Fayetteville Rd Ste 109
Durham, NC, 27713
Phone (919) 942-4424
Groups this clinician bills Medicare through
Medicare paid, 2024
$146K
21,790 services
Medicare patients, 2024
141
Average age 64
Drug cost, 2024
$1.4M
3,934 prescriptions
Company payments, 2025
$78K
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kevin A Kahn was code J0585 (injection, onabotulinumtoxina, 1 unit), 20,000 times for 34 patients. In total Kevin A Kahn billed 21,790 services in 22 codes, and Medicare paid $146K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 20,000 | 34 | $4.98 | $100K |
| 96136 Behavioral Health Services | Office | 294 | 127 | $24.41 | $7,177 |
| 64615 Musculoskeletal | Office | 81 | 29 | $94.06 | $7,619 |
| 99212 Office E&M - Established | Office | 78 | 40 | $31.19 | $2,433 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 63 | 21 | $23.65 | $1,490 |
| 99215 Office E&M - Established | Office | 52 | 40 | $113.12 | $5,882 |
| 99214 Office E&M - Established | Office | 50 | 37 | $69.60 | $3,480 |
| 99213 Office E&M - Established | Office | 49 | 38 | $44.97 | $2,204 |
| 64616 Musculoskeletal | Office | 49 | 14 | $128.55 | $6,299 |
| 99205 Office E&M - New | Office | 19 | 19 | $145.68 | $2,768 |
By year: 2022 $147K for 21,043 services; 2023 $140K for 20,826 services; 2024 $146K for 21,790 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kevin A Kahn prescribed most often to Medicare patients was Gabapentin, with 249 prescriptions and refills. In total Kevin A Kahn wrote 3,934 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 249 | 458 | 63 | $7,113 |
| Aimovig Autoinjector Erenumab-Aooe | 203 | 252 | 29 | $183K |
| Emgality Pen Galcanezumab-Gnlm | 170 | 194 | 23 | $139K |
| Sumatriptan Succinate Generic | 140 | 219 | 34 | $9,281 |
| Pregabalin Generic | 119 | 198 | 26 | $2,745 |
| Promethazine Hcl Generic | 112 | 112 | 35 | $1,535 |
| Nurtec Odt Rimegepant Sulfate | 109 | 117 | 22 | $185K |
| Ubrelvy Ubrogepant | 108 | 113 | 23 | $162K |
| Zonisamide Generic | 107 | 184 | 23 | $2,965 |
| Topiramate Generic | 101 | 211 | 26 | $2,150 |
| Naratriptan Hcl Generic | 85 | 113 | 31 | $3,062 |
| Rizatriptan Rizatriptan Benzoate | 77 | 157 | 25 | $2,885 |
| Botox Onabotulinumtoxina | 75 | 190 | 23 | $97K |
| Candesartan Cilexetil Generic | 74 | 148 | 15 | $4,385 |
| Emgality Syringe Galcanezumab-Gnlm | 74 | 84 | Under 11 | $120K |
Brand drugs: 1,098 claims; generic drugs: 2,836 claims; opioid claims: 115.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kevin A Kahn $78K ($78K in general payments such as food, travel and fees) from 11 companies. The largest payer was Abbvie Inc. with $37K.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 63 | $37K |
| Axsome Therapeutics, Inc. AXSM | 30 | $28K |
| Pfizer Inc. PFE | 22 | $12K |
| Impel Pharmaceuticals LLC | 11 | $230 |
| Lundbeck LLC | 10 | $169 |
| Tonix Medicines, Inc. | 5 | $142 |
| Teva Pharmaceuticals USA, Inc. TEVA | 3 | $64.96 |
| Merz Pharmaceuticals, LLC | 2 | $55.5 |
| Lilly USA, LLC LLY | 2 | $40.64 |
| Amneal Pharmaceuticals LLC AMRX | 1 | $23.96 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.